In summary, this study clarified the expression of G6PC in a variety of tumors, and its low expression was associated with poor prognosis of HCC, which may be used as a new potential prognostic marker and a potential molecular target for targeted therapy of HCC. Here, G6PC1 is linked to hepatocellular carcinoma.